Gerald P. Oetzel

CFO

Scott Rathgaber

CEO

3 past transactions

Flywheel.io

Series D in 2023
Flywheel.io is a cloud-based data management platform tailored for biomedical research and collaboration. Founded in 2012 and headquartered in Minneapolis, Minnesota, the company provides a suite of tools designed to enhance the workflow of scientists and researchers. Its platform supports medical imaging, scientific computation, and content management, enabling users to capture, manage, and analyze research data efficiently. By utilizing cloud scalability and automation, Flywheel facilitates collaborative research, machine learning applications, and multicenter studies, which help organizations streamline their research processes. The platform, featuring a modern web interface and extensible compute engine, aims to eliminate bottlenecks in innovation, allowing researchers to focus on scientific discovery rather than IT challenges.

Bellin Health

Acquisition in 2022
Bellin Health is an integrated healthcare delivery system based in Green Bay, Wisconsin, offering a comprehensive range of medical services. The organization includes hospitals, specialty care clinics, psychiatric centers, and fitness facilities, providing preventive and specialized care in areas such as cardiology, orthopedics, sports medicine, digestive health, mental health, and primary care. Bellin Health's services also encompass rehabilitation, surgery—including robotic-assisted procedures—cancer treatment, pulmonary care, and emergency services. Additionally, the system features a fitness center that offers group exercise, personal training, lifestyle medicine, weight management programs, and wellness events, promoting overall health and well-being for its patients and the community.

Digital Diagnostics

Series B in 2022
Digital Diagnostics Inc. is an artificial intelligence diagnostics company focused on enhancing healthcare through technology. Founded in 2010 by Michael Abramoff, MD, PhD, the company has developed a suite of autonomous algorithms that analyze medical images to detect various diseases. Its flagship products include IDx-DR, which identifies diabetic retinopathy; IDx-G, which monitors glaucoma indicators; and IDx-AMD, designed to detect age-related macular degeneration. The company also offers algorithms for diagnosing conditions such as Alzheimer's disease, cardiovascular disease, and stroke risk. By providing these innovative solutions, Digital Diagnostics aims to improve the quality, accessibility, equity, and affordability of healthcare worldwide. Operating from Coralville, Iowa, the company distributes its products both domestically and internationally, striving to integrate autonomous AI into standard clinical practices and enhance patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.